The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 331:539-541 August 25, 1994 Number 8
NextNext

Caveats about Elective Coronary Stenting

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Nearly 10 years ago, coronary-artery stents were developed with the hope of preventing restenosis after coronary angioplasty, a problem that has proved all too common. The first clinical report of coronary-artery stenting, by Sigwart and colleagues, was published in the Journal in 19871. In their study, permanent metal prosthetic coronary stents were used in conjunction with a rudimentary antithrombotic medical regimen; follow-up of the first cohort of patients suggested that this approach was associated with too many thrombotic complications2.

Perseverance in the past decade has led to considerable progress in coronary stenting. The Gianturco-Roubin stent, with its flexible-coil . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.